Valuation: Abbott Laboratories

Market Cap 202B 173B 162B 148B 278B 19,313B 282B 1,910B 744B 9,695B 758B 741B 32,079B P/E 2026 *
33.5x
P/E 2027 * 25.8x
Enterprise Value 226B 193B 181B 166B 311B 21,604B 315B 2,136B 833B 10,845B 848B 829B 35,884B EV / Sales 2026 *
4.49x
EV / Sales 2027 * 4.08x
Free-Float
86.16%
Yield 2026 *
2.2%
Yield 2027 * 2.35%
1 day-6.97%
1 week+12.73%
Current month+12.73%
1 month+11.71%
3 months+22.77%
6 months-8.15%
Current year-13.89%
1 week 105
Extreme 105
125.8
1 month 100
Extreme 100
125.8
Current year 90
Extreme 90
135
1 year 90
Extreme 90
144.1
3 years 90
Extreme 90
144.1
5 years 90
Extreme 90
144.1
10 years 90
Extreme 90
144.1
Manager TitleAgeSince
Chief Executive Officer 52 31/03/2020
Director of Finance/CFO 53 01/09/2023
Chief Investment Officer 51 -
Director TitleAgeSince
Director/Board Member 64 09/12/2011
Director/Board Member 67 09/12/2011
Director/Board Member 71 16/02/2017
Change 5-day change 1-year change 3-year change Capi.($)
-1.43%+12.73% - - 198B
+2.19%+4.83%-11.93%+12.47% 198B
+1.14%+3.06%+0.14%+14.51% 118B
+1.06%+2.59%+4.73%+76.30% 60.05B
-1.37%-6.27%+28.79%+60.98% 53.18B
+2.33%+5.51%-3.61%-29.85% 51.11B
+2.35%+0.94%+13.06%-12.93% 34.05B
+5.16%-3.71% - - 28.58B
-0.20%+2.00%+43.31%-8.95% 24.9B
+0.93%+0.79%-4.66%+6.28% 22.98B
Average +0.33%-0.37%+8.73%+14.85% 65.61B
Weighted average by Cap. -1.40%+0.83%+1.26%+17.72%

Financials

2026 *2027 *
Net sales 50.3B 43.07B 40.28B 36.88B 69.23B 4,813B 70.17B 476B 186B 2,416B 189B 185B 7,995B 54.65B 46.79B 43.76B 40.06B 75.21B 5,229B 76.23B 517B 202B 2,625B 205B 201B 8,685B
Net income 6.23B 5.34B 4.99B 4.57B 8.58B 596B 8.69B 58.97B 22.98B 299B 23.4B 22.89B 991B 7.92B 6.79B 6.35B 5.81B 10.91B 758B 11.05B 74.98B 29.23B 381B 29.75B 29.1B 1,260B
Net Debt 23.94B 20.5B 19.17B 17.55B 32.95B 2,291B 33.39B 227B 88.29B 1,150B 89.88B 87.91B 3,805B 20.96B 17.95B 16.78B 15.36B 28.84B 2,005B 29.23B 198B 77.29B 1,007B 78.68B 76.96B 3,331B
Logo Abbott Laboratories
Abbott Laboratories specializes in the research, development, manufacturing and marketing of pharmaceutical and medical products. Net sales break down by family of products as follows: - vascular devices (48.3%): endoprosthetic systems, dilation catheters, arterial closures, etc.; - diagnostic systems and instruments (20.2%); - nutrition products (19.1%): pediatric nutrition products, nutritional supplements, and dietetic products; - medicine (12.4%): anesthetics, antiviral products, antibiotics, inhibitors, anti-inflammatories, etc. Net sales are distributed geographically as follows: the United States (38.7%), Germany (6.2%), China (4.3%), India (4.2%), Switzerland (4.2%), Japan (3.3%), the United Kingdom (3%) and others (36.1%).
Employees
115,000
Date Price Change Volume
21/08/26 USD 113.70 +3.36% 3
20/08/26 USD 110.00 -11.29% 12
19/08/26 USD 124.00 -1.43% 5
18/08/26 USD 125.80 +19.81% 1
17/08/26 USD 105.00 -4.55% 2
Trader
Investor
Global
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
27
Last Close Price
116.64USD
Average target price
120.20USD
Spread / Average Target
+3.05%

Quarterly revenue - Rate of surprise